Transcript No Slide Title

Primary ESRD Modality in New ESRD Patients,
1995-97*
100
New Patients (%)
84.3
80
60
40
20
8.7
3.1
0.2
CCPD
IPD
0
Hemo
CAPD
*Reported on HCFA Medical Evidence Form
3.7
Transplant
IV -1
USRDS 1999
Demographic Characteristics of New ESRD
Patients, 1997*
80
New Patients (Age or %)
61.1
60
53.1
44.4
40
20
0
Average Age
*Reported on HCFA Medical Evidence Form
**Primary/contributing cause of ESRD
% Male
% Diabetes**
IV -2
USRDS 1999
Reported Race and Hispanic Ethnicity
among New ESRD Patients, 1997*
80
New Patients (%)
3000
63.5
60
Hispanic = 10.9%
overall
Number of People
Counts of races
included in "Other"
category
2000
1000
40
515
28.7
182
0
Middle
East
20
2.9
0
2189
White
Black
Indian
Subcontinent
1.1
Asian /
Native American /
Pacific Islander Alaskan Native
*Reported on HCFA Medical Evidence Form
Unknown race is not included in percentages.
Approximately 0.6% of patients reported race as “Unknown”.
Other/
Multicultural
3.8
Other
IV -3
USRDS 1999
Primary Detailed Disease Groups Reported
among New ESRD Patients, 1997*
60
New Patients (%)
44.4
40
26.6
20
9.9
7.6
2.3
0
Diabetes
Hypertension
3.9
Glomerulo- Secondary Interstitial
nephritis
GN/ Vascu- Nephritis
litis
PyeloNephritis
*Reported on HCFA Medical Evidence Form
3.3
2.0
Cystic/ Neoplasms/
Hereditary/ Tumors
Congenital
Miscellaneous
IV - 4
USRDS 1999
Primary Disease Reported among New ESRD
Patients by Year, 1995-97*
50
New Patients (%)
42.3
43.3
44.4
1995
40
30
1996
1997
26.6
26.0
25.8
20
17.917.316.8
11.310.8
9.9
10
2.7 2.5 2.4
0
Diabetes
Hypertension
*Reported on HCFA Medical Evidence Form
Glomerulonephritis
Cystic
Kidney
Disease
Other Causes
IV -5
USRDS 1999
Cardiovascular Patient Characteristics
among New Dialysis Patients, 1997*
40
New Patients (%)
34.7
30
25.1
20
15.6
9.7
9.4
10
0.9
0
Congestive
Heart
Failure
CAD
*Reported on HCFA Medical Evidence Form
MI
Cardiac
Arrest
CVD /
CVA/
TIA
Peripheral
Vascular
Disease
IV -6
USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Gender and Diabetes in New
Dialysis Patients, 1997*
40
New Patients (%)
CAD
30
MI
29.5
27.0
22.9
21.5
20
10.7
10.6
0
8.4
8.1
10
Male
Female
Gender
*Reported on HCFA Medical Evidence Form
Yes
No
Diabetes
IV -7
USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Age for New Dialysis Patients, 1997*
40
New Patients (%)
CAD
35.6
MI
32.8
30
20.6
20
12.2
10
12.8
8.1
4.6
2.0
0
20-44
45-64
*Reported on HCFA Medical Evidence Form
65-74
Age
75+
IV -8
USRDS 1999
Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Race and Hispanic Ethnicity in
New Dialysis Patients, 1997*
35
30
New Patients (%)
30.6
CAD
MI
25.7
25
22.0
20
15
17.6
14.8
11.8
9.8
9.3
10
5
0
20.2
19.5
White
5.1
5.6
5.9
Black
Asian
Native
Other
American
*Reported on HCFA Medical Evidence Form
6.0
Hispanic
NonHispanic
IV -9
USRDS 1999
Non-Cardiovascular Patient Characteristics
among New Dialysis Patients, 1997*
30
New Patients (%)
24.1
20
10
7.4
5.2
5.5
4.6
1.7
0
Diabetes
on insulin
COPD
Cancer
*Reported on HCFA Medical Evidence Form
Smoker
Inability to
Ambulate
Inability to
Transfer
IV -10
USRDS 1999
Serum Albumin and Body Mass Index (BMI)
for New ESRD Patients, 1995-98*
3.5
Average BMI (kg/m2)
Average Serum Albumin (g/dl)
3.4
3.3
27
26.05
3.25
3.22
3.2
25.39
3.20
25.52
26
25.67
3.19
25
3.1
3.0
24
1995
1996
1997
1998
1995
1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
IV -11
USRDS 1999
Distribution of Facilities by Average Number of
Comorbidities Reported per Patient, 1995-97*
60 Facilities (%)
55.6
N = 3,250 Facilities**
50
40
31.5
30
20
8.8
10
0
3.5
0.2
0
0.3
<1
1 to <2
2 to <3 3 to <4 4 to <5
Average Number of Comorbidities Reported
*Reported on HCFA Medical Evidence Form
**Excludes facilities with < 5 new patients in 3 years
0.1
5 to <6
IV -12
USRDS 1999
Distribution of Facilities by Percent of Patients
with Zero Comorbidities Reported, 1995-97*
40
Facilities (%)
33.0
30
N = 3,250 Facilities**
27.2
18.7
20
10
7.3
5.7
2.8
1.9
1.5
0
0
0+ to
10%
10+ to
20%
20+ to
30%
30+ to
40%
40+ to
50%
50+ to
60%
60+ to
70%
0.4
70+ to
80%
0.7
0.6
80+ to 90+ to
90% < 100%
0.2
100%
Percent of Patients with Zero Comorbidities Reported
*Reported on HCFA Medical Evidence Form
**Excludes facilities with < 5 new patients in 3 years
IV -13
USRDS 1999
Serum Creatinine and GFR
for New ESRD Patients by Age Group, 1995-97*
15
Average Serum Creatinine (mg/dl)
Average GFR (ml/min)**
15
10.8
10
8.7
7.5
7.0
6.6
7.1
7.7
8.0
10
5
5
0
0
20-44
45-64 65-74
Age
*Reported on HCFA Medical Evidence Form
**MDRD Formula
75+
20-44 45-64
65-74
Age
75+
IV -14
USRDS 1999
Serum Creatinine and Weight
for New ESRD Patients by Year, 1995-98*
10 Average Serum Creatinine (mg/dl)
9
8.7
71.3
Average Weight (kg) 80
71.8
72.1
73.0
8.5
70
8.1
8
8.0
60
7
6
1995
1996
1997
1998
1995 1996
*Reported on HCFA Medical Evidence Form; 1998 data are through June
1997
1998
50
IV -15
USRDS 1999
EPO Use Before ESRD by Age and Gender
for New ESRD Patients, 1995-97*
40
Receiving EPO Before ESRD (%)
30
22.9
23.8
24.6
20-44
45-64
65-74
23.9
75+
26.0
22.5
20
10
0
Age
*Reported on HCFA Medical Evidence Form
Female
Male
Gender
IV -16
USRDS 1999
EPO Use Before ESRD for New ESRD Patients
by Race and Hispanic Ethnicity, 1995-97*
40
30
Receiving EPO Before ESRD (%)
30.1
26.1
24.4
21.0
19.9
20
21.7
21.6
10
0
White
Black
Asian
Native Other
American
*Reported on HCFA Medical Evidence Form
Hispanic
NonHispanic
IV -17
USRDS 1999
Prior vs. Current Employment among New
ESRD Patients, Ages 20-64, 1997*
36
New Patients (%)
32
32
30
30
27
27
6 months before ESRD (missing = 10%)
At onset of ESRD (missing = 4%)
24
20
18
12
6 7
6
6 6
5
1
0
Employed** Unemployed Retired,
Disabled
Retired
by Age
Homemaker
*Reported on HCFA Medical Evidence Form.
**Includes part-time and full-time. Patients with employment status missing are excluded.
Medical
Leave
1 0.5
Student
IV -18
USRDS 1999